Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals

Drug and Alcohol Dependence

Volumn 107, Issue 1, 2010, Pages 69-75

  Grasing, Kenneth ^a,b   Mathur, Deepan ^a   Newton, Thomas F ^c   DeSouza, Cherilyn ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acetylcholine; Cholinesterase inhibitors; Cocaine; Cocaine related disorders; Donepezil

Indexed keywords

COCAINE; DONEPEZIL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG TOLERABILITY; DYSPHORIA; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VOMITING;

BEHAVIOR, ADDICTIVE; CHOLINESTERASE INHIBITORS; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; INDANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PIPERIDINES; REINFORCEMENT (PSYCHOLOGY);

ANIMALIA;

EID: 74749090979     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.09.010     Document Type: Article

References (44)

1. Baker J.R., Jatlow P., and Cance-Katz E.F. Disulfiram effects on responses to intravenous cocaine administration. Drug Alcohol Depend. 87 (2007) 202-209
2. Ballard C.G., Greig N.H., Guillozet-Bongaarts A.L., Enz A., and Darvesh S. Cholinesterases: roles in the brain during health and disease. Curr. Alzheimer Res. 2 (2005) 307-318
3. Beck A.T., Steer R.A., and Brown G.K. Beck Depression Inventory Manual (1996), The Psychological Corporation, San Antonio, TX
4. Birks J.S., and Harvey R. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst. Rev. (2003) CD001190
5. Blaha C.D., Allen L.F., Das S., Inglis W.L., Latimer M.P., Vincent S.R., and Winn P. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J. Neurosci. 16 (1996) 714-722
6. Comer S.D., Ashworth J.B., Foltin R.W., Johanson C.E., Zacny J.P., and Walsh S.L. The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend. 96 (2008) 1-15
7. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology. seventh ed. (1996), Oxford University Press, New York
8. Cryan J.F., Hoyer D., and Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol. Psychiatry 54 (2003) 49-58
9. De La Garza R., Mahoney III J.J., Culbertson C., Shoptaw S., and Newton T.F. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol. Biochem. Behav. 89 (2008) 200-208
10. De La Garza R., Shoptaw S., and Newton T.F. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int. J. Neuropsychopharmacol. (2008) 1-13
11. Degenhardt L., Chiu W.T., Sampson N., Kessler R.C., Anthony J.C., Angermeyer M., Bruffaerts R., de G.G., Gureje O., Huang Y., Karam A., Kostyuchenko S., Lepine J.P., Mora M.E., Neumark Y., Ormel J.H., Pinto-Meza A., Posada-Villa J., Stein D.J., Takeshima T., and Wells J.E. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS. Med. 5 (2008) e141
12. Derogatis L.R., and Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol. Med. 13 (1983) 595-605
13. Doody R.S., Corey-Bloom J., Zhang R., Li H., Ieni J., and Schindler R. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs Aging 25 (2008) 163-174
14. Dooley M., and Lamb H.M. Donepezil: a review of its use in Alzheimer's disease. Drugs Aging 16 (2000) 199-226
15. Gerrits M.A., Petromilli P., Westenberg H.G., Di Chiara G., and Van Ree J.M. Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats. Brain Res. 924 (2002) 141-150
16. Goldstein R.A., DesLauriers C., and Burda A.M. Cocaine: history, social implications, and toxicity-a review. Dis. Mon. 55 (2009) 6-38
17. Grasing K., He S., and Yang Y. Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats. Psychopharmacology 196 (2008) 133-142
18. Griffiths R.R., Troisi J.R., Silverman K., and Mumford G.K. Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav. Pharmacol. 4 (1993) 3-13
19. Halikas J.A., Kuhn K.L., Crosby R., Carlson G., and Crea F. The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale. Compr. Psychiatry 32 (1991) 22-27
20. Haney M., and Spealman R. Controversies in translational research: drug self-administration. Psychopharmacology 199 (2008) 403-419
21. Hikida T., Kaneko S., Isobe T., Kitabatake Y., Watanabe D., Pastan I., and Nakanishi S. Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens. Proc. Natl. Acad. Sci. USA 98 (2001) 13351-13354
22. Hikida T., Kitabatake Y., Pastan I., and Nakanishi S. Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc. Natl. Acad. Sci. USA 100 (2003) 6169-6173
23. Homma A., Imai Y., Tago H., Asada T., Shigeta M., Iwamoto T., Takita M., Arimoto I., Koma H., and Ohbayashi T. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial. Dement. Geriatr. Cogn. Disord. 25 (2008) 399-407
24. Jones H.E., Garrett B.E., and Griffiths R.R. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J. Pharmacol. Exp. Ther. 288 (1999) 188-197
25. Kaufman M.J., Levin J.M., Kukes T.J., Villafuerte R.A., Hennen J., Lukas S.E., Mendelson J.H., and Renshaw P.F. Illicit cocaine use patterns in intravenous-naive cocaine users following investigational intravenous cocaine administration. Drug Alcohol Depend. 58 (2000) 35-42
26. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 4 (1997) 231-244
27. Kollins S.H., and Rush C.R. Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans. Biol. Psychiatry 51 (2002) 143-150
28. Kowatch R.A., Schnoll S.S., Knisely J.S., Green D., and Elswick R.K. Electroencephalographic sleep and mood during cocaine withdrawal. J. Addict. Dis. 11 (1992) 21-45
29. Mark G.P., Rada P., Pothos E., and Hoebel B.G. Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum, and hippocampus of freely behaving rats. J. Neurochem. 58 (1992) 2269-2274
30. Martin W.R., Sloan J.W., Sapira J.D., and Jasinski D.R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin. Pharmacol. Ther. 12 (1971) 245-258
31. Mateo Y., Lack C.M., Morgan D., Roberts D.C., and Jones S.R. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology 30 (2005) 1455-1463
32. McLellan A.T., Luborsky L., Woody G.E., and O'Brien C.P. Guide to the Addiction Severity Index: Background, Administration, and Field-Testing Results (1985), Department of Health and Human Services, Rockville, MD
33. McNair D.M., Lorr M., and Doppleman L.F. Profile of Mood States (1971), Educational and Industrial Testing Service, San Diego
34. Mello N.K., Mendelson J.H., Sholar M.B., Jaszyna-Gasior M., Goletiani N., and Siegel A.J. Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men. Neuropsychopharmacology 30 (2005) 618-632
35. Mihara M., Ohnishi A., Tomono Y., Hasegawa J., Shimamura Y., Yamazaki K., and Morishita N. Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol. 31 (1993) 223-229
36. Parsons L.H., Koob G.F., and Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J. Pharmacol. Exp. Ther. 274 (1995) 1182-1191
37. Quality Enhancement Research Institute, 2008. V.H.A. Substance use disorders, www.hsrd.research.va.gov/publications/internal/sud_factsheet.pdf.
38. Rada P.V., and Hoebel B.G. Aversive hypothalamic stimulation releases acetylcholine in the nucleus accumbens, and stimulation-escape decreases it. Brain Res. 888 (2001) 60-65
39. Roache J.D., Johnson B.A., it-Daoud N., Mauldin J.B., Thornton J.E., Wells L.T., and Murff W.L. Effects of repeated-dose isradipine on the abuse liability of cocaine. Exp. Clin. Psychopharmacol. 13 (2005) 319-326
40. Substance Abuse and Mental Health Services Administration, 2008. D.o.H.a.H.S. Results of the 2007 national survey on drug use and health: national findings.
41. Takamatsu Y., Yamanishi Y., Hagino Y., Yamamoto H., and Ikeda K. Differential effects of donepezil on methamphetamine and cocaine dependencies. Ann. N.Y. Acad. Sci. 1074 (2006) 418-426
42. Williams M.J., and Adinoff B. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 33 (2008) 1779-1797
43. Winhusen T.M., Somoza E.C., Harrer J.M., Mezinskis J.P., Montgomery M.A., Goldsmith R.J., Coleman F.S., Bloch D.A., Leiderman D.B., Singal B.M., Berger P., and Elkashef A. A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100 Suppl. 1 (2005) 68-77
44. Yesavage J.A., Mumenthaler M.S., Taylor J.L., Friedman L., O'Hara R., Sheikh J., Tinklenberg J., and Whitehouse P.J. Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 59 (2002) 123-125